Redwood City, CA, United States of America

Ivan Ho Chan

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 24(Granted Patents)


Location History:

  • Redwood City, CA (US) (2018 - 2022)
  • Millbrae, CA (US) (2019 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovator Ivan Ho Chan: Pioneering Cancer Immunotherapy

Introduction

Ivan Ho Chan, an accomplished inventor based in Redwood City, California, has made significant contributions to the field of cancer immunotherapy. With a remarkable portfolio of 10 patents to his name, he has been at the forefront of developing innovative therapies, particularly focusing on genetically engineered immune cells.

Latest Patents

Among his latest inventions, Ivan has worked on the patent titled "Genetically modified natural killer cells for CD70-directed cancer immunotherapy." This patent presents several methods and compositions that enhance immune cells, specifically Natural Killer (NK) cells, by engineering them to express chimeric antigen receptors (CAR). This modification aims to reduce side effects typically associated with cellular immunotherapy while targeting CD70, particularly for renal cell carcinoma. Another notable patent involves "Methods of using interleukin-10 for treating diseases and disorders," which outlines innovative methods for treating various diseases, including cancer and immune-related disorders, through the administration of IL-10 combined with other therapeutic agents.

Career Highlights

Throughout his career, Ivan Ho Chan has held key positions in leading biotechnology companies, including Armo Biosciences, Inc. and Nkarta, Inc. His role in these organizations has allowed him to further his research and development efforts, translating cutting-edge scientific discoveries into practical therapeutic applications.

Collaborations

Ivan has collaborated with talented researchers and colleagues in the field, including John Brian Mumm and James Barnaby Trager. These partnerships have been instrumental in driving forward innovative research initiatives aimed at enhancing cancer treatment methodologies through advanced immunotherapy techniques.

Conclusion

Ivan Ho Chan exemplifies the spirit of innovation in the healthcare and biotechnology sectors. His dedication to developing groundbreaking immune therapies not only demonstrates his expertise but also highlights the crucial role of inventors in advancing medical science. With his ongoing contributions, the landscape of cancer treatment continues to evolve, offering hope to countless patients facing challenging diagnoses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…